BCL2 and cancer: Meanwhile, bcl2 levels were significantly (p < 0.001) decreased to 0.7 ng/mL ± 0.2 and 1.57 ng/mL ± 0.35 in HepG2 and A549 cancer cells, respectively, as shown in Figure 7B.